51
Views
9
CrossRef citations to date
0
Altmetric
Review

Synthetic vectors for gene therapy

Pages 199-208 | Published online: 25 Feb 2005

Bibliography

  • ZABNER J, FASBENDER AJ, MONINGER T et al: Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. (1995) 270 (32):18997–19007.
  • •A clear exposition on the obstacles to be overcome by transfection complexes.
  • PLANK C, MECHTLER K, SZOKA FC et al.: Activation of thecomplement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. (1996) 7:1437–1446.
  • KRIEG AM: Lymphocyte activation by CpG dinucleotidemotifs in prokaryotic DNA. Trends Microbiol (1996) 4 (2):73–76.
  • FELGNER PL, BARENHOLZ Y, BEHR JP et al: Nomencla-ture for synthetic gene delivery systems. Hum. Gene Ther. (1997) 8 (5):511–512.
  • FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: ahighly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413–7417.
  • •The first description of a lipoplex.
  • FELGNER JH, KUMAR R, SRIDHAR CN et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. (1994) 269(4):2550–2561.
  • CAPLEN NJ, ALTON EWFW, MIDDLETON PG et al:Liposome-mediated CF7'R gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Merl. (1995) 1(1):39–46.
  • UNGER EC, MCCREERY TP, SWEITZER RH: Ultrasoundenhances gene expression of liposomal transfection. Invest. Radio]. (1997) 32(12):723–727.
  • LAWRIE A, BRISKEN AF, FRANCIS SE et al.: Ultrasoundenhances reporter gene expression after transfection of vascular cells in vitro. Circulation (1999) 99(20)2617–2620.
  • MISLICK KA BALDESCHWIELER JD: Evidence for the roleof proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1996) 93(22):12349–12354.
  • MOUNKES LC, ZHONG W, CIPRES-PALACIN G et al.:Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. (1998) 273(40):26164–26170.
  • BELTING M, PETERSSON P: Protective role for proteo-glycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro. Biochem. J. (1999) 342 (Pt 2):281–286 (In Process Citation).
  • WU GY, WU CH: Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. (1987) 262(104429–4432.
  • •The first description of a targeted polyplex.
  • WU GY, WU CH: Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. (1988) 263(29)14621–14624.
  • PLANK C, ZATLOUKAL K, COTTEN M et al. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra- antennary galactose ligand. Bioconjug. Chem. (1992) 3(6):533–539.
  • KOLLEN WJ, SCHEMBRI FM, GERWIG GJ et al.: Enhanced efficiency of lactosylated poly-L-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells. Am. Respir. Cell Mol. Biol. (1999) 20(5):1081–1086.
  • BOUSSIF 0, LEZOUALCH F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in viva polyethylenimine. Proc. Natl. Acad. Sci. USA (1995) 92(16):7297–7301.
  • GODBEY WT, WU KK, MIKOS AG: Tracking the intracel-lular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA (1999) 96 (9):5177–5181.
  • ERBACHER P, REMY J-S, BEHR J-P: Gene transfer withsynthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. (1999) 6:138–145.
  • OGRIS M, STEINLEIN P, KURSA M et al.: The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. (1998) 5(10):1425–1433.
  • ZANTA MA, BOUSSIF 0, ADIB A et al.: In vitro gene delivery to hepatocytes with galactosylated polyeth-ylenimine. Bioconjug. Chem. (1997) 8(6):839–844.
  • DIEBOLD SS, KURSA M, WAGNER E et al.: Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. (1999) 274(27)19087–19094.
  • FERRARI S, MORO E, PETTENAZZO A et al.: ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther. (1997) 4(10):1100–1106.
  • COLL JL, CHOLLET P, BRAMBILLA E et al.: In vivo delivery to tumors of DNA complexed with linear polyethyleni-mine. Hum. Gene Ther. (1999) 10(10):1659–1666.
  • OGRIS M, BRUNNER S, SCHULLER S et al.: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6(4):595–605.
  • ZHANG F, ANDREASSEN P, FENDER P et al.: Atransfecting peptide derived from adenovirus fiber protein. Gene Ther. (1999) 6(2):171–181.
  • LEONG KW, MAO HQ, TRUONG-LE VL et al.: DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Rel. (1998) 53(1-3):183–193.
  • TRUONG-LE VL, WALSH SM, SCHWEIBERT E et al.: Genetransfer by DNA-gelatin nanospheres. Arch. Biochem. Biophys. (1999) 361 (1):47–56.
  • HART SL, COLLINS L, GUSTAFSSON K et al.: Integrin-mediated transfection with peptides containing arginine- glycine-aspartic acid domains. Gene Ther. (1997) 4(10:1225–1230.
  • HART SL, HARBOTTLE RP, COOPER R et al.: Gene delivery and expression mediated by an integrin-binding. Gene Ther. (1995) 2 (8):552–554.
  • HART SL, ARANCIBIA-CARCAMO CV, WOLFERT MA et al.: Lipid-mediated enhancement of transfection by a nonviral integrin- targeting vector. Hum. Gene Ther. (1998) 9(4):575–585.
  • YOON K, COLE-STRAUSS A, KMIEC EB: Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. Proc. Nati Acad. Sci. USA (1996) 93:2071–2076.
  • ••A potentially exciting new technology complementary tosynthetic vector systems.
  • BANDYOPADHYAY P, MA X, LINEHAN-STIEERS C et al.:Nucleotide exchange in genomic DNA of rat hepato-cytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J. Biol. Chem. (1999) 274(15):10163–10172.
  • KREN BT, BANDYOPADHYAY P, STEER CJ: In vivo site-directed mutagenesis of the Factor IX gene by chimeric RNA/DNA oligonucleotides. Nature Med. (1998) 4(3):285–290.
  • ••An astounding result for in vivo use of RNA/DNA chimeras.
  • COLE-STRAUSS A, YOON K, XIANG Y et al: Correction ofthe mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science (1996) 273:1386–1389.
  • GONCZ KK, KUNZELMANN K, XU Z et al.: Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments. Hum. Mol. Genet. (1998) 7(12):1913–1919.
  • YEW NS, MARSHALL J, PRZYBYLSKA M et al.: Increasedduration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3. Hum. Gene Ther. (1999) 10(101833–1843.
  • •A promising approach for prolonging the duration of transgene expression from viral promoters.
  • ARMENTANO D, SMITH MP, SOOKDEO CC et al. E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors. J. Virol. (1999) 73(8)7031–7034.
  • HUXLEY C: Mammalian artificial chromosomes and chromosome transgenics. Trends Genet. (1997) 13(9)345–347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.